Načítá se...
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
BACKGROUND: Interleukin-1 beta (IL-1β) and its key regulator, the inflammasome, are suspected to play a role in the neuroinflammation observed in Alzheimer’s disease (AD); no conclusive data are nevertheless available in AD patients. RESULTS: mRNA for inflammasome components (NLRP1, NLRP3, PYCARD, c...
Uloženo v:
| Vydáno v: | Mol Neurodegener |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4778358/ https://ncbi.nlm.nih.gov/pubmed/26939933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-016-0088-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|